Assessing the potential impact of COVID-19 on life expectancy
- PMID: 32941467
- PMCID: PMC7498023
- DOI: 10.1371/journal.pone.0238678
Assessing the potential impact of COVID-19 on life expectancy
Abstract
Background: The COVID-19 virus pandemic has caused a significant number of deaths worldwide. If the prevalence of the infection continues to grow, this could impact life expectancy. This paper provides first estimates of the potential direct impact of the COVID-19 pandemic on period life expectancy.
Methods: From the estimates of bias-adjusted age-specific infection fatality rates in Hubei (China) and a range of six prevalence rate assumptions ranging from 1% to 70%, we built a discrete-time microsimulation model that simulates the number of people infected by COVID-19, the number dying from it, and the number of deaths from all causes week by week for a period of one year. We applied our simulation to four broad regions: North America and Europe; Latin America and the Caribbean; Southeastern Asia; and sub-Saharan African. For each region, 100,000 individuals per each 5-year age group are simulated.
Results: At a 10% COVID-19 prevalence rate, the loss in life expectancy at birth is likely above 1 year in North America and Europe and in Latin America and the Caribbean. In Southeastern Asia and sub-Saharan Africa, one year lost in life expectancy corresponds to an infection prevalence of about 15% and 25%, respectively. Given the uncertainty in fatality rates, with a 50% prevalence of COVID-19 infections under 95% prediction intervals, life expectancy would drop by 3 to 9 years in North America and Europe, by 3 to 8 years in Latin America and the Caribbean, by 2 to 7 years in Southeastern Asia, and by 1 to 4 years in sub-Saharan Africa. In all prevalence scenarios, as long as the COVID-19 infection prevalence rate remains below 1 or 2%, COVID-19 would not affect life expectancy in a substantial manner.
Interpretation: In regions with relatively high life expectancy, if the infection prevalence threshold exceeds 1 or 2%, the COVID-19 pandemic will break the secular trend of increasing life expectancy, resulting in a decline in period life expectancy. With life expectancy being a key indicator of human development, mortality increase, especially among the vulnerable subgroups of populations, would set a country back on its path of human development.
Conflict of interest statement
The authors have declared that no competing interests exist.
Figures
References
-
- IHME. Update IHME COVID-19 Projections: Predicting the Next Phase of the Epidemic [Internet]. Seattle: Institute for Health Metrics and Evaluation (IHME); 2020 May [cited 2020 Aug 26]. Available from: http://www.healthdata.org/covid/updates
-
- Alimohamadi Y, Taghdir M, Sepandi M. The Estimate of the Basic Reproduction Number for Novel Coronavirus disease (COVID-19): A Systematic Review and Meta-Analysis. Journal of Preventive Medicine and Public Health [Internet]. 2020. March 20 [cited 2020 May 6]; Available from: https://www.jpmph.org/journal/view.php?doi=10.3961/jpmph.20.076 - PMC - PubMed
-
- Liu Y, Gayle AA, Wilder-Smith A, Rocklöv J. The reproductive number of COVID-19 is higher compared to SARS coronavirus. J Travel Med [Internet]. 2020. March 13 [cited 2020 Mar 25];27(2). Available from: https://academic.oup.com/jtm/article/27/2/taaa021/5735319 - PMC - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources